Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,778 GBX | -0.59% | -0.31% | +22.60% |
07:45pm | GSK on Zantac Litigation Says Will Continue To "Vigorously Defend" Itself Against All Claims | RE |
07:45pm | GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS… | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.60% | 92.82B | |
+37.73% | 723B | |
+34.28% | 595B | |
-4.64% | 369B | |
+19.95% | 332B | |
+2.59% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.26% | 168B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK, Scynexis Sign License Deal for Fungal Infection Treatment